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Abstract 
Autophagy has been implicated as a major factor in the development of a number of diseases of 
skeletal muscle. However, its role in skeletal muscle homeostasis is still evolving. We examined 
skeletal muscle architecture in a mouse model, Atg16L1, where autophagy is attenuated but 
importantly still present. We show that muscle fibres from Atg16L1 mice were smaller than wild-
type counterparts, proving a role for this process in the growth of these cells. We show that mild 
attenuation of autophagy results in accelerated muscle loss during the initial phase of acute 
starvation. Furthermore, we show that regeneration of skeletal muscle following cardiotoxin (CTX) 
mediated injury is slower in the Atg16L1 mouse compared to wild-type. Lastly, we show that 
autophagy controls the integrity of the sarcolemma. Attenuated autophagy makes muscle fibres 
more susceptible to infiltration by circulating immunoglobulins following muscle injury with CTX. 
These fibres internalise dystrophin and nNOS. Importantly these fibres are able to restore dystrophin 
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and nNOS localisation and do not die. In conclusion, these studies shed new light into the ability of 
skeletal muscle fibres to cope with injury and establish a link between the fine-tuning of autophagy 
and skeletal muscle regeneration. 
 
Introduction 
Maintenance of cellular homeostasis requires robust mechanisms to remove misfolded proteins, and 
in the case of eukaryotes, aberrant organelles. Both bacteria and eukaryotes degrade proteins in a 
subcellular structure called the proteasome [1].  In bacteria, a signal encoded in the primary protein 
sequence identifies polypeptides destined for proteasome degradation. In contrast, eukaryotes mark 
proteasome substrates through poly-ubiquitination [2]. Unlike prokaryotes, eukaryotes also contain 
membrane bound organelles which often malfunction and need to be eliminated. Removal of bulk 
cytoplasmic content and organelles in eukaryotes is mediated by one of two processes called 
microautophagy or macroautophagy. Microautophagy is the direct engulfment of organelles and 
cytoplasm by the lysosome. In contrast macroautophagy, hereafter referred to as autophagy, 
involves the formation of a double membrane structure around the degradation target, called the 
autophagosome, which subsequently fuses with the lysosome where the final process of breakdown 
occurs [3].  
Studies on autophagy stretch back to the 1950’s with the pioneering, mainly descriptive work of de 
Duve [4]. However, the molecular players in this process were not characterised not until the later 
part of the 20th century and the beginning of the 21st often using yeast as a model organism. A large 
number of autophagy related genes (ATG) have been identified (to date more than 30) in this 
organism that participate in this process [5]. Autophagy starts with the formation of a cup-like 
membrane structure called the phagopore. Autophagy can be divided into five key stages: (1) The 
phagopore formation or nucleation, a process that requires VSP34 in conjunction with many 
proteins including Beclin 1 to produce PI(3)P. (2) The conjugation of multimeric Atg5-Atg12-Atg16L 
complex to the extending phagopore, a process thought to induce curvature of the growing 
phagopore. (3) Processing and conjugation of microtubule-associated protein light chain 3 (LC3) into 
the phagopore. Maturation of LC3 requires it be lipidated through its conjugation with 
phosphatidylethanoalamine (PE). LC3 is proposed to be involved in the selection of proteins destined 
for autophagy [6]. (4) Capture of cytosol and/or organelle for degradation marked by the formation 
of the autophagosome (5) Fusion of autophagosome with the lysosome. 
Given that autophagy is a major mechanism that controls cellular content, it is hardly surprising that 
its deregulation plays a significant part in the development of human diseases. Mutations in key 
autophagy genes have been identified in a spectrum of ailments ranging from cancer, 
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neurodegenerative diseases to diseases of muscle (reviewed by Jiang and Mizushima [7]). Many 
human diseases have been modelled in mice through autophagy gene deletion or over ablation 
studies. Although these studies have been extremely instructive in understanding the role of 
autophagy during disease progression, they, by their robust nature, give relatively limited insights 
into the impact of this mechanism of tissue homeostasis. To achieve the later, a number of 
investigators have developed models in which autophagy is mildly increased or reduced. One such 
model which has proven the value of such an approach is the hypomorphic Atg16L1 mouse. Atg16L 
is a key component of autophagy. It forms a complex with Atg12 and Atg5 and has been shown to 
specify the site of LC3 lipidation of membrane biogenesis [8]. Cadwell and colleagues developed the 
Atg16L hypomorph mouse model called Atg16L1 in which the expression of the gene was 
diminished, but importantly not absent [9]. The Atg16L hypomorph mouse has decreased levels in 
autophagy in all tissues examined to date.  This mouse model was used to show that autophagy 
plays a role in the development of Crohn’s disease by controlling the activity of intestinal Paneth 
cells [9]. This mouse model has been extensively used to study the role of autophagy in other tissues 
and recently been shown to control stem cells developing in the brain, gut and bone [10]. The value 
of a hypomorph approach was exemplified in the later study, which showed that when autophagy 
was reduced, the outcome manifests in stem cells being maintained in an undifferentiated state. In 
contrast when key autophagy genes have been ablated this results in apoptosis of the neural stem 
cells [11].   
A large number of studies have investigated the role of autophagy in skeletal muscle development 
and its function. Most have relied on gene knock-out or over-expression strategies. These have 
shown that over-active or an absence of autophagy has a major impact on muscle mass and its 
ability to generate force [12, 13]. However very few have examined the physiological role played by 
autophagy in skeletal muscle. Here we have carried out a detailed investigation of the skeletal 
muscle of the Atg16L1 mouse. 
We show that autophagy plays a role in the hypertrophy of muscle fibres, allowing them to attain 
normal size. Additionally, we show that autophagy plays a significant role in coping with starvation 
induced stress and during the regeneration process following acute injury. Furthermore, we show a 
novel role for autophagy in maintain sarcolemma integrity. 
 
Results 
Autophagy and muscle fibre growth 
We first established the skeletal muscle phenotype of the Atg16L1 mouse. Atg16L1 mice were viable 
and were born at expected Mendelian ratios. In agreement with published works, the adult male 
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Atg16L1 mice in our study weighed the same as wild-types (Figure 1A) [9]. Examination of the 
weights of five hind limb muscles from Atg16L1 mice revealed that most were lighter than their wild-
type counterparts without reaching statistical significance (Figure 1B). We thereafter carried out a 
detailed examination of a relatively fast contracting, glycolytic muscle, the Extensor Digitorum 
Longus muscle (EDL) and the soleus muscle a slow contracting oxidative muscle to reveal potentially 
subtle muscle phenotype as a consequent of reducing ATG16 activity. There was no significant 
change in either fibre number or the proportion of fibres expressing the major Myosin Heavy Chain 
isoforms (MHC) in the EDL and Soleus (Figure 1C, D, K and L). However morphometric analysis 
revealed a small but significant decrease in the size of all MHC fibre types in both muscles (Figure 1E 
and M). Profiling of muscle fibres based on oxidative metabolic activity, on the basis of the 
proportion of fibres containing high levels of Succinate Dehydrogenase (SDH) revealed no 
differences between that of Atg16L1and wild-type. The fibre size decrease revealed through MHC 
profiling was also evident when plotted against SDH activity (Figure 1H and P). The numbers of 
capillaries associated with each muscle fibre (capillary density) was not affected by the Atg16L1 
mutation in either muscle (Figure 1I, Q, S-V)). Lastly, we assessed oxidative stress in the Atg16L1, 
since muscle relies on high levels of metabolic activity which generates reactive oxygen species 
(ROS). Firstly we assessed the levels of ROS using Dihydroethidium (DHE)[14]. We found that DHE 
levels were elevated in the muscle from Atg16L1 (Figure 1F and N). Thereafter we quantified the 
levels of lipid peroxidation which is caused by ROS, by examining the production of 4-hydroxy-2-
nonenal (4-HNE)[15]. We found higher levels of 4-HNE in the muscle from Atg16L1 compared to 
wild-type (Figure 1J and R). Examination of muscle after Haematoxylin and Eosin staining revealed 
the presence of numerous aberrant fibres (with centrally located nuclei, irregular shape, extremely 
small size) originating from Atg16L1 mice which were absent in wild-type tissue (Figure 1S-V). These 
results show that small changes in the level of autophagy results in subtle quantitative and 
qualitative changes in skeletal muscle biology. 
 
Starvation 
Autophagy has been shown to protect against nutrient stress through its ability to recycle amino 
acids to maintain viability [16]. We determined the impact of mildly attenuating autophagy following 
total nutrient withdrawal, by starving the two cohorts for a maximum period of 24h. Both wild-type 
and Atg16L1 mutant mice lost body weight at both 12h and 24h of food deprivation (Figure 2A). 
Importantly at both time points the impact on body weight loss was greater in Atg16L1 than wild-
type (Figure 2A).  This was also the case for individual muscle groups at 12h but not at 24h of 
starvation, when both cohorts had lost similar levels of muscle compared to fed mice (Figure 2B). All 
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fibre types, irrespective of MHC isoform expression or expression of SDH had undergone atrophy in 
both cohorts during the starvation experiment. Importantly, during the first 12h of starvation, 
atrophy was more pronounced in the Atg16L1 mutant mice than wild-type (Figure 2C). However, by 
24h, both cohorts had similar sized fibres with respect to MHC isoform and SHD expression level 
classification (Figure 2D). An almost identical effect of starvation was noted in the soleus muscle of 
Atg16L1 mutant mice compared to wild-type (Supplementary Figure 1). We examined the 
mechanisms underpinning the accelerated muscle loss in the first 12h of starvation in Atg16L1 
mutant mice. Gene expression showed that the expression of Foxo3 a key regulator of catabolic 
process was induced to a greater level in Atg16L1 mutant mice than wild-type at 12h of starvation 
(Figure 2E). We found that key genes encoding regulators of the proteasome degradation pathway, 
Atrogin and MuRF were robustly induced in both cohorts (Figure 2F-G). Next, we investigated, at the 
protein level, the abundance of key regulators of muscle mass (Figure 2H). The levels of active 
FoxO3a (determined by the phosphorylation status of Serine 320, a process mediated by kinases 
including Akt [17]) was increased by starvation in both cohorts (Figure 2J). The level of activated AKT 
(Serine 473) as well as a downstream target (S6- Serines 240 and 244) were down-regulated by 
starvation at 12h in both cohorts (Figure 2K-J).  The level of peIF2a a measure of ribosomal assembly 
inactivation (Serine 51) was induced by starvation only in Atg16L1 mutant mice (Figure 2L). 
Expression of OPA1, a key molecule required to maintain mitochondrial function and subcellular 
localisation[18] was greatly reduced  in both cohorts by 12h of food deprivation (Figure 2M). 
However, we found that whereas there was robust induction of autophagy, assessed by quantifying 
lipidated levels of LC3, by 12h of starvation in wild-type mice (Figure 2N) there was no such outcome 
in Atg16L1 mutant mice (Figure 2N). We also found that the levels of another autophagy protein, 
p62, were increased in WT after 12 hours of starvation, but not in muscle of Atg16L1 mutant mice 
(Figure 2O). We also investigated the levels of poly-ubiquitination and found a significantly higher 
degree in the muscle of Atg16L1 mutant mice than wild-type after 12h of starvation (Figure 2P).  
At 24h of starvation, we detected similar elevated levels of FoxO3, Atrogin and MuRF in the two 
cohorts (Figure 2Q-S). Western blotting showed robust increase in the levels of activated FoxO3a in 
both genotypes after 24h of starvation (Figure 2T-U).  Western blot analysis showed that protein 
synthesis mediated by AKT through S6 were significantly inhibited in both cohorts by starvation 
(Figure 2V-W). Interestingly inhibition of ribosomal assembly was alleviated by prolonged starvation 
in both cohorts (Figure 2X). Expression of OPA1 was also different at 24h compared to 12h. Herein 
the levels which were previously repressed were now normal in both cohorts (Figure 2Y). 
Nevertheless, autophagy as judged by the level of LC3 lipidation was elevated in muscle of wild-type 
mice after 24h of starvation but had not been induced even after this time in Atg16L1 mutant mice 
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(Figure 2Z). Levels of p62 were similar in the muscle of both starved cohorts (Figure 2AA). Levels of 
poly-ubiquitination were similar in both cohorts at 24h (Figure 2AB)., 
 
Muscle Regeneration 
Next, we assessed the effect of small changes in the level of autophagy on muscle regeneration. To 
that end, the Tibialis Anterior muscle (TA) was damaged using cardiotoxin (CTX), a process known to 
kill muscle fibres without impacting on satellite cells, and examined at two separate time points at 
which regeneration starts (three days post-injury) and late phase of regeneration (six days post-
injury)[19].  
There was a clear impact of genotype in terms of degeneration evidenced by the density of damaged 
fibres (assessed by the number being infiltrated by circulating Ig molecules) three days after injury. 
In damaged areas, there were five times more damaged muscle fibres in the TA of Atg16L1 
compared to wild-type (Figure 3A-B). The size of damaged fibres was the same between the 
genotypes (Figure 3C) as was the size of regenerating fibres (Figure 3D-E). Six days after muscle 
damage, the density of damaged fibres was still higher in the Atg16L1 albeit not reaching statistical 
significance (Figure 3F and I). The size of damaged fibres had decreased to similar levels in both 
genotypes (Figure 3G). However, the size of regenerating fibres was significantly smaller in the 
Atg16L1 compared to wild-type (Figure 3H and J). We profiled the status of satellite cells and their 
descendants to gain an insight into the attenuated muscle regeneration displayed by Atg16L1 mice. 
Profiling of muscle stem cells (Pax7+/MyoD-), muscle precursors (Pax7+/MyoD+) and committed 
myoblasts (Pax7-/MyoD+)[20] revealed that Atg16L1 satellite cells were held back from 
differentiating, evidenced by more cells being in the stem cell state, with a deficit in numbers in both 
the precursor and in the committed myoblast state (Figure 3K). 
These results show that attenuated autophagy impacts on both the myofibre and muscle stem cells; 
making fibres more prone to infiltration after CTX administration insult and skewing the satellite cell 
differentiation program towards stem cell status and away from differentiation. 
 
Sarcolemma fragility and autophagy 
During the examination of muscle following CTX injection we noted a major feature that segregated 
only with the Atg16L1 mutation. We found there was extensive infiltration of circulating Igs into 
fibres that appeared otherwise normal, three days after CTX injection in the muscle from Atg16L1 
mice but not wild-type (Figure 4A). We called this area ‘leaky’ which as otherwise stated appeared 
normal, this area had normally sized muscle fibres, the nuclei were peripherally located and there 
was no sign of cellular infiltration between fibres (see DAPI imaged in Figure 4A). The leaky area 
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covered the vast majority of the TA muscle from Atg16L1 mice except in three areas. The first was in 
the damaged region which could be readily identified by the significant level of cellular infiltration 
between damaged fibres, with the fibres in that area also smaller than in other regions. There were 
an additional two regions where fibres were of normal size and lacked intra-fibre Ig infiltration and 
inter-fibre cellular infiltration, one at a site furthest from the point of CTX injection (labelled 
‘undamaged in Figure 4A) and one lateral to the central TA tendon (identifiable by the auto-
fluorescence in the wild-type image in Figure 4A). Importantly by day six after CTX injection, the 
leaky area in the Atg16L1 muscle had been completely resolved, supported by the lack of Ig 
molecules inside muscle fibres (Figure 4B). 
We investigated whether the leakiness of Atg16L1 muscle fibres following exposure to CTX had an 
impact on key muscle proteins. To that end we focused on key molecules (dystrophin, nNOS and 
collagen IV) that protect muscle from contraction mediated damage and profiled their distribution in 
undamaged, leaky and damaged regions in the two cohorts [21]. Dystrophin was localised to the 
sarcolemma in both cohorts at equal levels (gauged by semi-quantitative immunofluorescence) in 
undamaged regions (Figure 5A-F). In damaged regions of both cohorts, we found that dystrophin 
was present but was localised to an equal extent within the muscle fibre (Figure 5A, C, D and F). The 
most striking difference at day three with regards to dystrophin localisation between the two 
cohorts was in the leaky region; the wild-type muscle has a pattern like that of undamaged region, 
whereas corresponding region of Atg16L1 muscle showed presence of dystrophin within the muscle 
fibre (Figure 5A-C). By day six, dystrophin localisation within the leaky area of Atg16L1 muscle had 
reverted to the normal sarcolemma position albeit at lower levels than wild-type (Figure 5D-F). Next, 
we examined the impact of leaky fibres on the localisation of nNOS at the sarcolemma, which is 
totally dependent on its interaction with dystrophin [22]. Both at the qualitative and quantitative 
levels, we found that the distribution of nNOS mirrored that of dystrophin; nNOS was localised at 
the muscle sarcolemma in undamaged regions in both cohorts but in the fibre in damaged regions 
(Figure 5G-I). Additionally, like dystrophin, the leaky area showed intra-fibre localisation of nNOS 
only in the Atg16L1 muscle at day three (Figure 5G-I) which was resolved by day 6 (Figure 5J). 
However, levels of nNOS at the sarcolemma of leaky fibres were lower in Atg16L1 muscle than wild-
type (Figure 5K-L). Lastly we examined the localisation and levels of a collagen IV a basal lamina 
component, which is bound by the dystrophin associated glycoprotein complex[23]. Compared to 
undamaged regions, the damaged regions at day three of either cohort appeared to be less uniform 
in terms of immunostaining signal intensity around the muscle fibre as well as in the thickness of the 
expression domain (Figure 5M). The non-uniform and varying thickness pattern was evident in the 
leaky muscle area of Atg16L1 muscle (Figure 5M). This feature was resolved at day 6 (Figure 5N). 
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Discussion 
Autophagy plays two major functions in animals. Firstly, its basal activity maintain the homeostatic 
function of tissues by acting as quality control mechanism, by promoting the degradation of 
malfunctioning organelles and toxic protein aggregates[3]. Additionally, autophagic activity can be 
induced in response a variety of stress conditions to act as an adaptive mechanism that underpins 
cell survival[24]. Skeletal muscle fibres rely heavily on autophagy due to their cellular nature. Muscle 
fibres are long lived cells and being unable to divide, they cannot dilute the accumulation of aberrant 
organelles and proteins through cell division[25]. Additionally autophagy mobilises the large stores 
of protein in skeletal muscle, which serve as source of amino acids to support the function of other 
organs during periods of stress [26, 27]. It is now firmly established that too much or too little 
autophagic activity have catastrophic impact on muscle function and the health of mammals [12, 
13]. However, there is a dearth of knowledge regarding the physiological role of autophagy on 
skeletal muscle structure and its responsiveness to stress and injury.  Here, we show that mild 
attenuation of autophagy reveals a role for this process in skeletal muscle homeostasis and ability to 
cope with acute nutritional and cellular stress.  
Genetic diminution of autophagy by decreasing Atg16 function in mice did not impact on embryonic 
survival. Mice were born at expected Mendelian ratios and grew at the same rate as wild-type 
littermates (Figure 1A and unpublished data). The skeletal muscle of Atg16L1 mice appeared on the 
whole normal at the histological level. Skeletal muscle development seems to be refractory to 
decreases in the level of autophagy; the tissue forms differentiated fibres capable of contraction 
even when autophagy has been completely inhibited [28, 29]. This contrasts to the situation in the 
brain, where neurogenesis has been shown to be affected even after mild perturbation in autophagy 
as in the Atg16L1 mouse [10]. However, there are major differences in muscle when autophagy has 
been completely inhibited to when it is only mildly attenuated. The most striking and obvious 
difference is at the level of muscle weight. In this study we show that a decrease in autophagy 
manifests in a slight, albeit non-significant, decrease in muscle mass which contrasts starkly to the 
40% decreases noted in muscle from mice where this activity was absent[28].  Nevertheless, we 
have been able to discern a physiological role for autophagy in muscle mass maintenance through 
the examination of fibre sub-types by showing that all fibres, categorised on MHC expression profile 
or oxidative capacity, rely on autophagy to attain their normal size. However, mild attenuation of 
autophagy had no role in the patterning of muscle fibres either on the basis of MHC profile or SDH 
expression. In agreement with the latter point, the capillary density of muscle fibres, a parameter 
regulated by the oxidative capacity of muscle fibres was not changed by a decrease in Atg16 
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function[30]. Molecular examination of skeletal muscle revealed that autophagy plays a major 
physiological role in preventing the build-up of ROS and limiting the harmful effects of this molecule. 
We show that even a mild attenuation of autophagy leads to at least a doubling of the level of ROS 
in muscle and significant increase in the degree of lipid peroxidation. One would predict, based on 
previous studies, that although the structure of muscle from Atg16L1 mice appeared normal, that 
the build-up of ROS would have detrimental effects on muscle biology. Assessment of muscle 
function through the determination of specific force and contraction times were beyond the scope 
of this study but will be the focus of future investigations together with an ultra-structural profiling 
of Atg16L1 muscle for signs of organelle damage. 
The importance of autophagy in regulating the functioning of muscle was truly revealed when the 
Atg16L1 mice were subjected to nutritional stress and acute damage. Here we found a significant 
response based on genotype to these insults. We show that attenuated Atg16 function led to 
significantly more muscle being lost in the first 12h of starvation compared to wild-type mice. In 
both genotypes, starvation induced robust expression of FoxO3a a gene that encodes a master 
regulator of muscle atrophy through its ability to promote the expression of a number of L3 
ubiquitin ligases including Atrogin and Murf1[31].  Given that these factors have been induced in 
both genotypes, it is important to offer an explanation of the greater degree of muscle loss in 
Atg16L1 mice. Again, the level of protein synthesis controlled through AKT was similarly affected by 
starvation in both genotypes. However, there were key differences between the genotypes when we 
examined the impact starvation had on autophagy. In agreement with previous studies, autophagy, 
as measured by lipidated LC3 levels, was induced in the muscle of wild-type mice by starvation [32]. 
In contrast there was no induction of autophagy by starvation in Atg16L1 mice. An important point 
to highlight is the presence of basal levels autophagy in fed Atg16L1 mice, which was not enhanced 
by starvation. This contrasts other studies in which key regulators of autophagy have been 
completely removed. In these studies there was no basal, let alone inducible autophagy [28, 29]. We 
believe that the blunted response in the Atg16L1 genotype to starvation, in terms of autophagy, 
could be the key to increased levels of muscle loss identified in the first 12h. We suggest that the 
absence of autophagy in the muscle of Atg16L1 mice initiates other programmes to minimise stress 
and to deal with the build-up of abnormal proteins. Our data shows genotype-specific inhibition of 
eIF2α activity, a process usually controlled by the phosphorylation activity of PERK [33]. Inactivation 
of eIF2α not only inhibits protein synthesis as it is essential for the assembly of ribosomes but is also 
a component of the Unfolded Protein Response which becomes activated as a reaction to 
Endoplasmic Reticulum stress[34].  Furthermore, we show a significant increase in the degree of 
protein poly-ubiquitination only in the muscle of starved Atg16L1 mice. We propose that in the 
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absence of a starvation inducible autophagic response, the muscle of Atg16L1 mice undergoes a 
period of accelerated muscle loss due to attenuated protein synthesis and high levels of poly-
ubiquitin mediated polypeptide degradation. The latter two features have been documented in 
other stress related conditions, including age-related loss of mitochondrial function [35]. We note 
that by 24h of starvation both genotypes had lost the same amount of muscle. Presently, we do not 
know why they rate of muscle loss in the Atg16L1 mice slow in the second 12h period following 
starvation. However recent work has shown that mechanisms exist that prevent excessive muscle 
loss in the face of degeneration and atrophy and are controlled by the expression of Myostatin [36].  
Herein it is thought that muscle loss can be mediated by Myostatin expression, but that it is down-
regulated if it becomes excessive. In such a scenario, one would predict that in the first 12h of 
starvation, the expression of Myostatin would be higher in Atg16L1 mice than WT. Thereafter, due 
to excessive muscle loss, its expression in Atg16L1 mice would be decreased in comparison to WT. 
However we believe that muscle loss in the WT cohort is coordinated where as in the Atg16L1 mice 
it is not.  Future work will investigate the hypothesis that although the two cohorts had experienced 
the same degree of muscle loss by 24h that deregulated atrophy in the absence of an inducible 
autophagic programme would have negatively impacted on the physiology of Atg16L1 tissue and 
through the assessment of Myostatin, Activin and GDF11 levels in the circulation. 
Lastly, we show that inducible autophagy has a major impact on muscle regeneration. Our results 
show that autophagy has a role to play in the regeneration of new fibres, the clearance on dying 
fibres and the stability of muscle fibres to CTX insult. Our work shows that at day 6 after CTX injury 
the size of newly formed muscle fibres of Atg16L1 were about half the size of wild-types. We 
propose that the deficit in the size of newly formed muscle fibres could in part be due to the impact 
of attenuated autophagy on the activity of Satellite Cells (SC) the resident stem cells of skeletal 
muscle[37, 38]. Satellite cells normally exist in a quiescent state with low metabolic activity [39]. 
They contain granules composed of translation initiation factors, RNA binding proteins and mRNA 
and are poised for activation and proliferation, a process kept in check through the inhibition of 
protein synthesis, mediated to a large extent by the phosphorylation of eIF2α[40, 41]. Autophagy is 
required for satellite cells to come out of their quiescent state through its ability to generate ATP 
needed for activation and proliferation [39].  Furthermore in the context of muscle regeneration, 
autophagy may also control the differentiation programme as it has been recently been shown that 
it promotes the Notch degradation, a process that would promote the development of committed 
myoblasts at the expense of stem cells [10].  We show that regenerating muscle from Atg16L1 mice 
had a greater proportion of muscle stem cells (Pax7+/MyoD-) and lower proportion of muscle 
precursors (Pax7+/MyoD+) or committed myoblasts (Pax7-/MyoD+) than wild-type. Therefore, we 
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postulate that the attenuated muscle regeneration in the Atg16L1 mice, evidenced by the smaller 
size of newly formed fibres (eMHC+) could be due to a lack of activation of stem cells after damage. 
This may lead to fewer myoblasts being generated to drive regeneration at its normal pace. These 
results are concordant for a role for autophagy in the differentiation of stem cells which has been 
previously described in the brain, gut and bone marrow[10]. 
Our work also identified a novel role for autophagy in the maintenance of sarcolemma integrity. We 
showed that injection of CTX in the TA muscle of Atg16L1 mice resulted in the fibres becoming leaky 
and infiltrated by circulating Ig molecules. Although these fibres exhibited additional molecular 
abnormalities such as the intra-fibre localisation of dystrophin and nNOS, they did not die and were 
able to essentially restore the two proteins to their normal site (albeit to a lower level than normal 
for nNOS). CTX brings about muscle fibre death through the activity of Phospholipase A2 (PLA2) 
which binds to proteins on the sarcolemma followed by hydrolysis of phospholipids [42, 43]. 
Puncturing of the sarcolemma by PLA2 causes a rapid fall in the resting membrane potential and a 
rise in the cytosolic concentration of Ca2+ which activates not only proteases but also leads to the 
demise of mitochondria and ultimately fibre death[44, 45]. The mechanism by which autophagy 
makes muscles fibres resilient to the action CTX needs to be determined but one important feature 
discovered by this work is that leaky fibres with altered sub-sarcolemma organisation (intra-fibre 
dystrophin and nNOS) are not necessarily destined to die. It is generally accepted that elevated 
levels of cytosolic Ca2+ are key mediators of muscle fibre death in muscular dystrophies or by the 
action of snake venoms. However the muscle fibre has a capacity to buffer against changes in 
cytosolic Ca2+ for example through the activity of mitochondria[46].  We propose that at sites of high 
CTX concentration, the cytosolic levels of Ca2+ cannot be buffered to prevent the activation of fibre 
necrosis, resulting in not only the death of the fibre but also infiltration by macrophages and the 
activation of satellite cells to regenerate lost tissue. However, fibres that experience a lower level of 
CTX become leaky but are able to buffer the rise in Ca2+ to levels insufficient to activate necrosis and 
all the other associated cellular events. Herein we speculate that autophagy is required to maintain 
membrane integrity and in its absence fibres become leaky at low levels of CTX which nevertheless 
are able to keep Ca2+ to sub-lethal levels. 
In summary, our study shows that modest alteration in autophagy reveals a role for this process in 
muscle fibre growth as well as coping with starvation and acute injury. Importantly this work 
demonstrated the value on hypomorphic models of autophagy, where this process is altered slightly 
which may expose the physiological role played by this process in animals.  
 
Methods 
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Mice 
Healthy BL6/BC122 WT or ATG16L1 mice were bred and maintained in accordance to the Animals 
(Scientific Procedures) Act 1986 (UK) and approved by the University of Reading  and University of 
Cambridge local ethics committees. The experiments were performed under a project license from 
the United Kingdom Home Office in agreement with the Animals (Scientific Procedures) Act 1986 
(PPL70/7516). The University of Reading Animal Care and Ethical Review Committee (AWERB) 
approved all procedures. Animals were humanely sacrificed via Schedule 1 killing between 8:00–
13:00. Mice were housed under standard environmental conditions (20–22°C, 12–12 hr light–dark 
cycle) and provided food and water ad libitum.  8-week-old mice were used in this study.  
Starvation protocol 
Mice were moved from communal housing in normal cages to single housing cages containing a 
water source as well as copious inedible bedding material to mitigate any effects of hypothermia. 
Animals were monitored every 6 hours and maintained under starvation conditions for a maximum 
of 24h. 
Immunohistochemistry 
 Dissected and frozen muscles (EDL, Soleus and TA) were mounted in Tissue Tech Freezing Medium 
(Jung) cooled by a dry ice/ethanol bath and cryosectioned at 10 µm thick sections using a Bright OTF 
cryostat (OTF/AS-001/HS) and placed onto glass slides for immunohistochemistry.  Slides were 
removed from -80°C, air dried for 30 minutes at room temperature (RT) prior to three washes in 1 x 
PBS. Muscle sections were incubated in permeabilisation buffer solution (0.952 g Hepes, 0.260 g 
MgCl2, 0.584 g NaCl, 0.1 g Sodium azide, 20.54 g Sucrose and 1 ml Triton X-100 in 200 ml dH2O) for 
15 minutes at room temperature. To remove excess permeabilisation buffer, another three five 
minutes washes in 1 x PBS were performed before the application of block wash buffer (PBS with 5% 
foetal calf serum (v/v), 0.05% Triton X-100) for 30 minutes at room temperature. 
Primary antibodies were pre-blocked in wash buffer for 30 minutes prior to application onto muscle 
sections overnight at 4°C. In order to remove the primary antibodies, muscle sections were washed 
three times in wash buffer with each wash lasting 10 minutes. Primary antibodies were identified 
using Alexa flour 488, 594 and 633 secondary antibodies. All secondary antibodies were pre-blocked 
in wash buffer for minimum of 30 minutes prior to their application onto the slides (1 hr in the dark 
at room temperature). Thereafter the muscle sections were washed three-10 minutes washes in PBS 
to remove the secondary antibody. Finally, slides were mounted in fluorescent mounting medium, 
and myonuclei were visualized using (2.5μg/ml) 4, 6-diamidino-2-phenylindole (DAPI). Details of 
primary and secondary antibodies are given in Supplementary Data File 1. 
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Succinate dehydrogenase (SDH) staining 
Muscle sections were incubated for 3 - 5 minutes at room temperature in a sodium phosphate 
buffer containing 75 mM sodium succinate (Sigma), 1.1 mM Nitroblue Tetrazolium (Sigma) and 1.03 
mM Phenazine Methosulphate (Sigma). Samples were then fixed in 10% formal-calcium and cleared 
in xylene prior to mounting with DPX mounting medium (Fisher). Densitometry of the samples was 
performed on a Zeiss Axioskop2 microscope mounted with an Axiocam HRc camera. Axiovision Rel. 
4.8 software was used to capture the images. 
 
Dihydroethidium (DHE) and 4-hydroxy-2-nonenal (4-HNE) staining 
Muscle sections were rehydrated in 1 x PBS for 5 minutes before being incubated with 10 µM of DHE 
(Sigma-Aldrich 7008) 30 minutes at 37°C or 4-HNE antibody.  The slides were then washed in 1 x PBS 
three times with each wash lasting 5 minutes. Finally, slides were mounted in fluorescent mounting 
medium, and myonuclei were visualised using (2.5 µg/ml) 4, 6-diamidino-2-phenylindole (DAPI).  
 
Quantitative PCR 
Frozen Gastrocnemius muscles were cut into three thirds, and (40 – 50 mg) pieces of each muscle 
pulverised and solubilised in TRIzol® (Fisher) using a tissue homogenizer (QIAGEN). Total RNA was 
isolated and purified using the RNesay Mini Kit (Quigen, Manchester, UK, 74104). RNA 
concentrations were measured using the Nanodrop 2000 (Thermo Scientific). RNA (5μg) was 
reverse-transcribed to cDNA with SuperScript II Reverse Transcriptse (Invitrogen) and analysed by 
quantitative real-time RT-PCR on a StepOne Plus cycler, using the Applied Biosystems SYBR-Green 
PCR Master Mix. Primers were designed using the software Primer Express 3.0 (Applied Biosystems). 
Relative expression was calculated using the ΔΔCt method with normalization to the housekeeping 
genes cyclophilin-B and hypoxanthine-guanine phosphoribosyltransferase (HPRT). Specific primer 
sequences are given in Supplementary Data File. 
Capillary density quantification 
Muscles sections (EDL and Soleus) were immunostained using CD31 antibody in order to identify the 
number of blood vessels that serve each muscle fibre. Quantification of capillary density was 
performed by selecting central area of muscle sections that includes approximately 150 to 200 fibres 
The number of muscle fibres were determined as well as the number of CD31+ in the selected area. 
Thereafter the ratio of blood capillaries to fibres (C:F) was calculated. 
 
Antigen retrieval immunostaining for Pax7/MyoD quantification 
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In order to quantify positive Pax7 and MyoD cells and to improve the presentation of our target 
antigens and enhance immunoreactivity, pre-treatment with the antigen retrieval reagents was 
performed. Sectioned slides were fixed in 4% PFA for 20 minutes at RT and incubated in 100% 
methanol for 5 minutes before being immersed into the preheated retrieval solution for 2-10 
minutes. Following the incubation, three five minutes washes in 1 x PBS were performed to remove 
excess retrieval solution from the slides. Sectioned slides were then pre-blocked in wash buffer for 
30 minutes at room temperature before being incubated with primary antibodies (Pax7 and MyoD) 
overnight at 4°C. Primary antibodies were identified using anti- mouse or anti rabbit Alexa fluor 488, 
594 and 633 secondary antibodies. Steps of day 2 of immunostaining protocol were followed before 
slides being mounted in fluorescent mounting medium and coverslip was placed over the top.  
Quantification of positive Pax7 and MyoD cells was performed by counting nuclei in the damaged 
areas of TA muscles, then counting the number of Pax7+ expressing cells or MyoD+ expressing cells or 
cells that expressed bothPax7+/MyoD+. Example of Pax7/MyoD stating is given in Supplementary 
figure X. A positive signal was only noted where the expression of either epitope co-localised to a 
DAPI stained nuclei. Data is presented as the number of events per square millimetre of damaged 
muscle. Example of Pax7 and MyoD immunohistochemistry of damaged muscle is given in 
Supplementary Figure 2. 
 
Western blotting 
Frozen gastrocnemius muscles were powdered and lysed in a buffer containing 4 M Urea, 125 mM 
Tris pH 6.8, 4% SDS and protease inhibitor cocktail set 1 (calbiochem). Protein concentration was 
determined via Bradford Assay (BioRad). 30 µg protein for each sample was resolved on a 4-12% SDS 
page gel (Life Technologies) prior to 3 hour transfer at 30 V on to a PVDF membrane (Thermo 
Scientific) for immunoblotting (details of antibodies used are given in supplementary information 
file). Blots were visualised with ECL™ Prime Western Blotting System (GE Healthcare). Images of 
Western blots were taken using ImageQuant LAS 4000 mini, ensuring they were below signal 
saturation. Protein expression was quantified using Fiji software and normalised to the expression of 
housekeeping proteins.We followed the journals guidelines for the presentation of Western blot 
data. All antibodies were initially characterised so that blotting conditions gave unequivocal 
recognition of the correct epitope, wherein entire blotting membrane was used. Examples of such 
blots are given in Supplementary Figure 3. Thereafter after blotting, membranes were sometimes 
cuts (guided by the molecular weight of a particular epitope and processed with different antibodies.  
This practice maximised the data return for a given amount of biological sample. Presentation of 
 
 
15 
 
individual bands sometimes required cropping for purely repositioning purposes and was used for 
clarity and presentational purposes alone.   
 
Semi-quantitative Measures of Sarcolemma Protein Expression 
Intensity of signals from the protein of interest was measured as previously described [47, 48]. 
Briefly, membrane signal intensities of approximately 30 muscle fibres of each MHC phenotype (IIA 
and IIB) in all muscle sections from wild type and Atg16L1 were analyzed. Images of muscle sections 
after immunostaining were firstly captured using Zeiss AxioImager A1, then tiles assembled into 
whole muscle image using Photoshop CS3 as JPEG files. Fiji software was used to measure the signal 
from the JPEG pictures of the area of interest after images had been corrected for background to 
avoid signal saturation. To calculate relative signal intensity levels, individual measurements from 
treated and control fibres were taken as a percentage of mean of control samples. The same process 
was used for DHE and 4-HNE quantification. 
 
Imaging and analysis  
Zeiss AxioImager A1 microscope was used to examine immunofluorescent stained sections, and 
images were captured using an Axiocam digital camera with Zeiss Axiovision computer software 
version 4.8. 
 
Statistical Analysis 
Data are presented as mean ± SE. Significant differences between two groups were performed by 
two-tailed Student’s t test for independent variables. Differences among groups were analyzed by 
two-way ANOVA followed by Bonferroni multiple comparison tests as appropriate. Statistical 
analysis was performed on GraphPad Prism software. Differences were considered statistically 
significant at *p < 0.05, **p < 0.01, or ***p < 0.001. 
 
References 
 
1. Jastrab, J.B. and K.H. Darwin, Bacterial Proteasomes. Annu Rev Microbiol, 2015. 69: p. 109-
27. 
2. Hughes, T. and T.E. Rusten, Origin and evolution of self-consumption: autophagy. Adv Exp 
Med Biol, 2007. 607: p. 111-8. 
3. Mizushima, N., et al., Autophagy fights disease through cellular self-digestion. Nature, 2008. 
451(7182): p. 1069-75. 
4. De Duve, C., et al., Tissue fractionation studies. 6. Intracellular distribution patterns of 
enzymes in rat-liver tissue. Biochem J, 1955. 60(4): p. 604-17. 
5. Mizushima, N., Autophagy: process and function. Genes Dev, 2007. 21(22): p. 2861-73. 
 
 
16 
 
6. Schwarten, M., et al., Nix directly binds to GABARAP: a possible crosstalk between apoptosis 
and autophagy. Autophagy, 2009. 5(5): p. 690-8. 
7. Jiang, P. and N. Mizushima, Autophagy and human diseases. Cell Res, 2014. 24(1): p. 69-79. 
8. Fujita, N., et al., The Atg16L complex specifies the site of LC3 lipidation for membrane 
biogenesis in autophagy. Mol Biol Cell, 2008. 19(5): p. 2092-100. 
9. Cadwell, K., et al., A key role for autophagy and the autophagy gene Atg16l1 in mouse and 
human intestinal Paneth cells. Nature, 2008. 456(7219): p. 259-63. 
10. Wu, X., et al., Autophagy regulates Notch degradation and modulates stem cell development 
and neurogenesis. Nat Commun, 2016. 7: p. 10533. 
11. Wang, C., et al., FIP200 is required for maintenance and differentiation of postnatal neural 
stem cells. Nat Neurosci, 2013. 16(5): p. 532-42. 
12. Carmignac, V., et al., Autophagy is increased in laminin alpha2 chain-deficient muscle and its 
inhibition improves muscle morphology in a mouse model of MDC1A. Hum Mol Genet, 2011. 
20(24): p. 4891-902. 
13. Grumati, P., et al., Autophagy is defective in collagen VI muscular dystrophies, and its 
reactivation rescues myofiber degeneration. Nat Med, 2010. 16(11): p. 1313-20. 
14. Benov, L., L. Sztejnberg, and I. Fridovich, Critical evaluation of the use of hydroethidine as a 
measure of superoxide anion radical. Free Radic Biol Med, 1998. 25(7): p. 826-31. 
15. Pillon, N.J., et al., The lipid peroxidation by-product 4-hydroxy-2-nonenal (4-HNE) induces 
insulin resistance in skeletal muscle through both carbonyl and oxidative stress. 
Endocrinology, 2012. 153(5): p. 2099-111. 
16. Mizushima, N., et al., In vivo analysis of autophagy in response to nutrient starvation using 
transgenic mice expressing a fluorescent autophagosome marker. Mol Biol Cell, 2004. 15(3): 
p. 1101-11. 
17. Wang, X., S. Hu, and L. Liu, Phosphorylation and acetylation modifications of FOXO3a: 
Independently or synergistically? Oncol Lett, 2017. 13(5): p. 2867-2872. 
18. Romanello, V. and M. Sandri, Mitochondrial Quality Control and Muscle Mass Maintenance. 
Front Physiol, 2015. 6: p. 422. 
19. Harris, J.B. and M.A. Johnson, Further observations on the pathological responses of rat 
skeletal muscle to toxins isolated from the venom of the Australian tiger snake, Notechis 
scutatus scutatus. Clin Exp Pharmacol Physiol, 1978. 5(6): p. 587-600. 
20. Zammit, P.S., et al., Muscle satellite cells adopt divergent fates: a mechanism for self-
renewal? J Cell Biol, 2004. 166(3): p. 347-57. 
21. Gumerson, J.D. and D.E. Michele, The dystrophin-glycoprotein complex in the prevention of 
muscle damage. J Biomed Biotechnol, 2011. 2011: p. 210797. 
22. Brenman, J.E., et al., Nitric oxide synthase complexed with dystrophin and absent from 
skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell, 1995. 82(5): p. 743-52. 
23. Allamand, V., et al., ColVI myopathies: where do we stand, where do we go? Skelet Muscle, 
2011. 1: p. 30. 
24. Onodera, J. and Y. Ohsumi, Autophagy is required for maintenance of amino acid levels and 
protein synthesis under nitrogen starvation. J Biol Chem, 2005. 280(36): p. 31582-6. 
25. Gundersen, K., Muscle memory and a new cellular model for muscle atrophy and 
hypertrophy. J Exp Biol, 2016. 219(Pt 2): p. 235-42. 
26. Brook, M.S., D.J. Wilkinson, and P.J. Atherton, Nutrient modulation in the management of 
disease-induced muscle wasting: evidence from human studies. Curr Opin Clin Nutr Metab 
Care, 2017. 20(6): p. 433-439. 
27. Lecker, S.H., A.L. Goldberg, and W.E. Mitch, Protein degradation by the ubiquitin-proteasome 
pathway in normal and disease states. J Am Soc Nephrol, 2006. 17(7): p. 1807-19. 
28. Masiero, E., et al., Autophagy is required to maintain muscle mass. Cell Metab, 2009. 10(6): 
p. 507-15. 
 
 
17 
 
29. Raben, N., et al., Suppression of autophagy in skeletal muscle uncovers the accumulation of 
ubiquitinated proteins and their potential role in muscle damage in Pompe disease. Hum Mol 
Genet, 2008. 17(24): p. 3897-908. 
30. Omairi, S., et al., Enhanced exercise and regenerative capacity in a mouse model that violates 
size constraints of oxidative muscle fibres. Elife, 2016. 5. 
31. Sandri, M., et al., Foxo transcription factors induce the atrophy-related ubiquitin ligase 
atrogin-1 and cause skeletal muscle atrophy. Cell, 2004. 117(3): p. 399-412. 
32. Collins-Hooper, H., et al., Symmorphosis through dietary regulation: a combinatorial role for 
proteolysis, autophagy and protein synthesis in normalising muscle metabolism and function 
of hypertrophic mice after acute starvation. PLoS One, 2015. 10(3): p. e0120524. 
33. Teske, B.F., et al., The eIF2 kinase PERK and the integrated stress response facilitate 
activation of ATF6 during endoplasmic reticulum stress. Mol Biol Cell, 2011. 22(22): p. 4390-
405. 
34. Hetz, C., E. Chevet, and H.P. Harding, Targeting the unfolded protein response in disease. Nat 
Rev Drug Discov, 2013. 12(9): p. 703-19. 
35. Tezze, C., et al., Age-Associated Loss of OPA1 in Muscle Impacts Muscle Mass, Metabolic 
Homeostasis, Systemic Inflammation, and Epithelial Senescence. Cell Metab, 2017. 25(6): p. 
1374-1389 e6. 
36. Mariot, V., et al., Downregulation of myostatin pathway in neuromuscular diseases may 
explain challenges of anti-myostatin therapeutic approaches. Nat Commun, 2017. 8(1): p. 
1859. 
37. Mauro, A., Satellite cell of skeletal muscle fibers. J Biophys Biochem Cytol, 1961. 9: p. 493-5. 
38. Collins, C.A., et al., Stem cell function, self-renewal, and behavioral heterogeneity of cells 
from the adult muscle satellite cell niche. Cell, 2005. 122(2): p. 289-301. 
39. Tang, A.H. and T.A. Rando, Induction of autophagy supports the bioenergetic demands of 
quiescent muscle stem cell activation. EMBO J, 2014. 33(23): p. 2782-97. 
40. Crist, C.G., D. Montarras, and M. Buckingham, Muscle satellite cells are primed for 
myogenesis but maintain quiescence with sequestration of Myf5 mRNA targeted by 
microRNA-31 in mRNP granules. Cell Stem Cell, 2012. 11(1): p. 118-26. 
41. Zismanov, V., et al., Phosphorylation of eIF2alpha Is a Translational Control Mechanism 
Regulating Muscle Stem Cell Quiescence and Self-Renewal. Cell Stem Cell, 2016. 18(1): p. 79-
90. 
42. Dixon, R.W. and J.B. Harris, Myotoxic activity of the toxic phospholipase, notexin, from the 
venom of the Australian tiger snake. J Neuropathol Exp Neurol, 1996. 55(12): p. 1230-7. 
43. Gasanov, S.E., R.K. Dagda, and E.D. Rael, Snake Venom Cytotoxins, Phospholipase A2s, and 
Zn(2+)-dependent Metalloproteinases: Mechanisms of Action and Pharmacological 
Relevance. J Clin Toxicol, 2014. 4(1): p. 1000181. 
44. Harris, J.B., et al., Muscle fibre breakdown in venom-induced muscle degeneration. J Anat, 
2003. 202(4): p. 363-72. 
45. Burr, A.R. and J.D. Molkentin, Genetic evidence in the mouse solidifies the calcium hypothesis 
of myofiber death in muscular dystrophy. Cell Death Differ, 2015. 22(9): p. 1402-12. 
46. Williams, G.S., et al., Mitochondrial calcium uptake. Proc Natl Acad Sci U S A, 2013. 110(26): 
p. 10479-86. 
47. Arechavala-Gomeza, V., et al., Immunohistological intensity measurements as a tool to 
assess sarcolemma-associated protein expression. Neuropathol Appl Neurobiol, 2010. 36(4): 
p. 265-74. 
48. Taylor, L.E., et al., Quantification of dystrophin immunofluorescence in dystrophinopathy 
muscle specimens. Neuropathol Appl Neurobiol, 2012. 38(6): p. 591-601. 
 
Acknowledgment  
 
 
18 
 
This work was supported by Ministry of Higher Education of Iraq and the Biotechnology and 
Biological Sciences Research Council (BBSRC-UK) for funding this research through award to DV 
(BB/M014878/1).  DCR is  grateful to the Wellcome Trust (Principal Research Fellowship to DCR 
(095317/Z/11/Z)), a Strategic Grant to Cambridge Institute for Medical Research (100140/Z/12/Z), 
and the UK Dementia Research Institute (funded by the MRC, Alzheimer’s Research UK and the 
Alzheimer’s Society)  for funding. We are also grateful to two annonymous reviewers for their 
constructive criticism during the review process.  
 
Author information 
 
Author affiliation 
School of Biological Sciences, University of Reading. Reading. UK 
Andrea Paolini, Saleh Omairi, Robert Mitchell, Danielle Vaughan and Ketan Patel 
 
Molecular Physiology Laboratory, Centre for Atherothrombotic & Metabolic Disease, Hull York 
Medical School, Hull, UK 
Antonios Matsakas 
 
School of Pharmacy, University of Reading. Reading. UK 
Sakthi Vaiyapuri 
 
Cambridge Institute for Medical Research, Department of Medical Genetics, University of Cambridge, 
UK 
Thomas Ricketts, David Rubinsztein 
 
UK Dementia Research Institute, Cambridge Biomedical Campus, Cambridge, UK 
David Rubinsztein 
 
Author contribution Conceptualisation KP, AM, DR. Methodology KP AM, SV, TR. Investigation AP, 
SO, RM, DV. Writing DR, KP. Supervision KP. 
 
Corresponding author Ketan Patel School of Biological Sciences, University of Reading, Whiteknights, 
Reading, RG6 6UB. Email: ketan.patel@reading.acc.uk 
 
 
 
19 
 
Competing interests 
The authors declare no competing interests. 
 
Data availability 
All relevant data related to this manuscript are available from the authors upon reasonable request 
 
 
Legends 
Figure 1. Characterisation of Atg16L1 skeletal muscle from male mice. (A) Body weight. (B) Weight of 
hind limb muscles. (C) Muscle fibre count at the mid-belly of the EDL. (D) MHC profile of EDL muscle. 
(E) MHC fibre size of EDL muscle. (F) Quantification of ROS levels using DHE in the EDL muscle. (G) 
Profiling the proportion of SHD positive fibres in the EDL. (H) SDH fibre size profiling of the EDL. (I) 
EDL capillary density. (J) Quantification of lipid peroxidation using 4-HNE in the EDL. (K) Muscle fibre 
count at the mid-belly of the soleus. (L) MHC profile of soleus. (M) MHC fibre size of the soleus. (N) 
Quantification of ROS levels using DHE in the soleus. (O) Profiling the proportion of SHD positive 
fibres in the soleus. (P) SDH fibre size profiling of the soleus. (Q) Soleus capillary density. (R) 
Quantification of lipid peroxidation using 4-HNE in the soleus. (S-T) CD31 staining to identify 
capillaries in EDL muscle. (U-V) CD31 staining to identify capillaries in the soleus.   (X-Y) H and E stain 
of EDL muscle. (Z-AA) H and E stain of soleus muscle. Centrally located nuclei indicated by black 
arrow and necrosing muscle fibre highlighted with the blue arrow in ATG16L1 muscle. Scale bar 
represents 100µm.  n=4-6 8-week-old-male for each cohort. *p<0.05 and **p<0.01. Statistical 
analysis between two groups performed by two-tailed Student’s t test for independent variables. 
 
Figure 2. Accelerated muscle atrophy in Atg16L1 mice induced by starvation. (A) Body mass decrease 
at 12 and 24h after total food withdrawal. Expressed as a percentage lost compared to normally fed 
mice. (B) Muscle loss (percent of normal) following total food withdrawal. (C) Morphometric analysis 
of EDL fibres after 12 h of starvation and (D) at 24h after food withdrawal. Changes in (E) FoxO3, (F) 
Atrogin and (G) MuRF1 in the gastrocnemius after 12h of starvation. (H) Western blot of key proteins 
from the gastrocnemius after 12h of starvation. Quantification of gastrocnemius protein expression 
for (I) pFox3a (J) pAKT, (K) pS6, (L) peIF2a, (M) OPA1, (N) LC3II/LCI (O) p62, and (P) levels of total 
poly-ubiquitination using EP8589 after 12h of starvation. Changes in (O) FoxO3, (P) Atrogin and (Q) 
MuRF1 in the gastrocnemius after 24h of starvation. (T) Western blot of key proteins from the 
gastrocnemius after 24h of starvation. Quantification of gastrocnemius protein expression for (U) 
pFox3a (V) pAKT, (W) pS6, (X) peIF2a, (Y) OPA1, (Z) LC3II/LCI (AA) p62, and (AB) levels of total poly-
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ubiquitination using EP8589 after 24h of starvation.  n=3-4 8-week-old-female for each cohort. 
*p<0.05, **p<0.01 and ***p<0.001. Statistical analysis between two groups performed by two-tailed 
Student’s t test for independent variables. 
 
 
Figure 3. Attenuated regeneration of Atg16L1 skeletal muscle after acute damage. (A) Identification 
of muscle fibres infiltrated by circulating Ig in wild-type and Atg16L1 TA muscle at day 3 post injury 
(arrows). (B) Quantification of Ig infiltrated necrotic fibres, (C) necrotic fibre size and (D) size of 
regenerating muscle fibres 3 days after injury. (E) Immunocytochemical image of embryonic MHC 
localisation to identify regenerating muscle fibres 3 days after injury (arrows). (F) Quantification of Ig 
infiltrated necrotic fibres, (G) necrotic fibre size and (H) size of regenerating muscle fibres 6 days 
after injury. (I) Identification of muscle fibres infiltrated by circulating Ig in wild-type and Atg16L1 TA 
muscle at day 6 post injury (arrows). (J) Immunocytochemical image of embryonic MHC localisation 
6 days after injury (arrows). (K) Quantification of Pax7 and MyoD immunocytochemical expression in 
regenerating muscle at day 6 after injury. n=3/4 8-week-old-male for each cohort. *p<0.05, 
**p<0.01. Statistical analysis between each two groups performed by two-tailed Student’s t test for 
independent variables. 
 
Figure 4. Sarcoplasmic fragility and autophagy. (A) Ig levels detected using immunocytochemistry 
three days after CTX injection. Damaged areas identified by the presence of small sized infiltrated 
fibres which also contain centrally located nuclei as well as huge levels of cellular infiltration. Leaky 
are only present at day three in muscle of Atg16L1 TA identified by Ig infiltration but fibres in this 
area are regular in shape and same size as in undamaged muscle. Additionally note no centrally 
located nuclei or cellular infiltration (A leaky area of Atg16L1 muscle). (B) Infiltration of Ig in Atg16L1 
muscle resolved by day six. n=3/4 8-week-old-male for each cohort. 
 
Figure 5. The impact of attenuated autophagy following acute muscle damage on components of the 
dystrophin associated glycoprotein complex. (A) Immunocytochemical analysis of dystrophin 
expression in undamaged, leaky and damaged regions at day three. Arrows show presence of 
dystrophin within the fibre in leaky area in Agt16L1 muscle. Quantification of dystrophin levels at the 
sarcolemma (B) and with the fibre (C) with relation to muscle fibre type in three regions of interest 
at day three. Note all quantification levels compared to a baseline of 1 of undamaged type IIA fibres.  
(D) Immunocytochemical analysis of dystrophin expression in undamaged, leaky and damaged 
regions at day six. Quantification of dystrophin levels at the sarcolemma (E) and with the fibre (F) 
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with relation to muscle fibre type in three regions of interest at day six. (G) Immunocytochemical 
analysis of nNOS expression in undamaged, leaky and damaged regions at day three. Arrows 
highlight nNOS within the fibre in leaky area in Agt16L1 muscle.  Quantification of nNOS levels at the 
sarcolemma (H) and with the fibre (I) with relation to muscle fibre type in three regions of interest at 
day three. (J) Immunocytochemical analysis of nNOS expression in undamaged, leaky and damaged 
regions at day six. Quantification of nNOS levels at the sarcolemma (K) and with the fibre (L) with 
relation to muscle fibre type in three regions of interest at day six. Immunocytochemical analysis of 
Collagen IV expression at day three (M) and day six (N) in undamaged, leaky and damaged regions in 
the two cohorts. Arrows in (M) highlight non-uniform collagen expression in Atg16L1 muscle at day 
three. Scale bar 100µm. n=3/4 8-week-old-male for each cohort. *p<0.05, **p<0.01 and ***p<0.001. 
Statistical analysis between two groups performed by two-tailed Student’s t test for independent 
variables.  
 
Supplementary data Figure 1. Effect of starvation on muscle fibres of the soleus. (A) Morphometric 
analysis of soleus fibres after 12 h of starvation and (B) at 24h after food withdrawal. 
 
Supplementary data Figure 2. Image of immunohistochemical staining for expression of Pax7 and 
MyoD of Atg16L1 TA muscle 6 days after injury with cardiotoxin. Green arrows indicate expression of 
nuclear PAx7, red arrows indicate expression of MyoD in the nuclei and yellow arrows indicate nuclei 
expressing both Pax7 and MyoD.  
 
Supplementary data Figure 3. Examples of whole membranes examined for the abundance of 
FoxO3a, S6 and LC3 in muscle extracts by Western Blotting.  
 
 
 
 





